MANKIND PHARMA
Quarterly Results Analysis [Sep2025]
MANKIND PHARMA Quarterly Results
| Consolidated | Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹3,697 Cr | ₹3,570 Cr | ₹3,079 Cr | ₹3,230 Cr | ₹3,061 Cr | ₹2,868 Cr | ₹2,422 Cr | ₹2,607 Cr |
| Expenses | ₹2,776 Cr | ₹2,724 Cr | ₹2,396 Cr | ₹2,400 Cr | ₹2,214 Cr | ₹2,196 Cr | ₹1,836 Cr | ₹2,000 Cr |
| Operating Income | ₹921 Cr | ₹847 Cr | ₹683 Cr | ₹830 Cr | ₹847 Cr | ₹672 Cr | ₹586 Cr | ₹607 Cr |
| Other Income | ₹92 Cr | ₹80 Cr | ₹251 Cr | ₹77 Cr | ₹109 Cr | ₹99 Cr | ₹92 Cr | ₹70 Cr |
| Interest | ₹170 Cr | ₹171 Cr | ₹191 Cr | ₹221 Cr | ₹7 Cr | ₹11 Cr | ₹9 Cr | ₹9 Cr |
| Depreciation | ₹222 Cr | ₹219 Cr | ₹231 Cr | ₹192 Cr | ₹100 Cr | ₹103 Cr | ₹100 Cr | ₹110 Cr |
| Profit Before Tax | ₹622 Cr | ₹537 Cr | ₹513 Cr | ₹494 Cr | ₹849 Cr | ₹657 Cr | ₹570 Cr | ₹558 Cr |
| Profit After Tax | ₹518 Cr | ₹441 Cr | ₹427 Cr | ₹381 Cr | ₹659 Cr | ₹535 Cr | ₹475 Cr | ₹455 Cr |
| EPS | ₹12.39 | ₹10.62 | ₹10.20 | ₹9.22 | ₹16.31 | ₹13.39 | ₹11.76 | ₹11.33 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| MANKIND PHARMA | 1.4% | -6.9% | -15.2% |
| SUN PHARMACEUTICAL INDUSTRIES | 3.5% | 6.2% | -4.2% |
| DIVIS LABORATORIES | -2.7% | -0.7% | 11% |
| CIPLA | 1.2% | -1.4% | -4.1% |
| TORRENT PHARMACEUTICALS | 0.6% | 9.1% | 19.7% |
| DR REDDYS LABORATORIES | 3.9% | 0.6% | -3.7% |
| ZYDUS LIFESCIENCES | -0.3% | -3.6% | -2.5% |
| LUPIN | 3.4% | 6.1% | -2.4% |
| AUROBINDO PHARMA | 6% | 8.8% | -8.9% |
MANKIND PHARMA Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 3.55 % |
| Y-o-Y | 20.77 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2025 | ₹3,697 Cr | 3.55 | |
| Jun2025 | ₹3,570 Cr | 15.94 | |
| Mar2025 | ₹3,079 Cr | -4.66 | |
| Dec2024 | ₹3,230 Cr | 5.51 | |
| Sep2024 | ₹3,061 Cr | 6.75 | |
| Jun2024 | ₹2,868 Cr | 18.40 | |
| Mar2024 | ₹2,422 Cr | -7.09 | |
| Dec2023 | ₹2,607 Cr | - | |
MANKIND PHARMA Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 8.81 % |
| Y-o-Y | 8.75 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2025 | ₹921 Cr | 8.81 | |
| Jun2025 | ₹847 Cr | 23.94 | |
| Mar2025 | ₹683 Cr | -17.67 | |
| Dec2024 | ₹830 Cr | -2.05 | |
| Sep2024 | ₹847 Cr | 26.15 | |
| Jun2024 | ₹672 Cr | 14.54 | |
| Mar2024 | ₹586 Cr | -3.33 | |
| Dec2023 | ₹607 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 5.06 % |
| Y-o-Y | -9.94 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2025 | 24.92% | 5.06 | |
| Jun2025 | 23.72% | 6.89 | |
| Mar2025 | 22.19% | -13.62 | |
| Dec2024 | 25.69% | -7.16 | |
| Sep2024 | 27.67% | 18.15 | |
| Jun2024 | 23.42% | -3.22 | |
| Mar2024 | 24.2% | 4.04 | |
| Dec2023 | 23.26% | - | |
MANKIND PHARMA Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 17.31 % |
| Y-o-Y | -21.38 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2025 | ₹518 Cr | 17.31 | |
| Jun2025 | ₹441 Cr | 3.46 | |
| Mar2025 | ₹427 Cr | 11.96 | |
| Dec2024 | ₹381 Cr | -42.14 | |
| Sep2024 | ₹659 Cr | 23.22 | |
| Jun2024 | ₹535 Cr | 12.66 | |
| Mar2024 | ₹475 Cr | 4.24 | |
| Dec2023 | ₹455 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 13.35 % |
| Y-o-Y | -34.90 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2025 | 14.01 % | 13.35 | |
| Jun2025 | 12.36 % | -10.82 | |
| Mar2025 | 13.86 % | 17.46 | |
| Dec2024 | 11.8 % | -45.17 | |
| Sep2024 | 21.52 % | 15.45 | |
| Jun2024 | 18.64 % | -4.85 | |
| Mar2024 | 19.59 % | 12.20 | |
| Dec2023 | 17.46 % | - | |
MANKIND PHARMA Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 16.67 % |
| Y-o-Y | -24.03 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2025 | ₹12.39 | 16.67 | |
| Jun2025 | ₹10.62 | 4.12 | |
| Mar2025 | ₹10.2 | 10.63 | |
| Dec2024 | ₹9.22 | -43.47 | |
| Sep2024 | ₹16.31 | 21.81 | |
| Jun2024 | ₹13.39 | 13.86 | |
| Mar2024 | ₹11.76 | 3.80 | |
| Dec2023 | ₹11.33 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD